scholarly journals Urethral bulking agents: a retrospective review of primary versus salvage procedure outcomes

Author(s):  
Ciara M. E. Daly ◽  
Jini Mathew ◽  
Judey Aloyscious ◽  
Suzanne Hagen ◽  
Veenu Tyagi ◽  
...  
Author(s):  
Aparna Hegde ◽  
G. Willy Davila ◽  
S. Abbas Shobeiri

2013 ◽  
Vol 29 (6) ◽  
pp. 255-259 ◽  
Author(s):  
Lindsay Denson ◽  
S. Abbas Shobeiri

2009 ◽  
Vol 181 (4) ◽  
pp. 617 ◽  
Author(s):  
Angelish Kumar ◽  
Victor W Nitti

2020 ◽  
Author(s):  
Svjetlana Lozo ◽  
Sylvia M Botros

Conservative management of stress urinary incontinence (SUI) is generally offered as first-line treatment. Such treatment options include behavioral therapy, pelvic floor muscle therapy, vaginal devices, pharmacologic therapy, and urethral bulking agents. Weight loss management is an example of an effective behavioral strategy in obese patients. Pelvic floor physical therapy alone or under the supervision of skilled providers can significantly improve SUI; however, long-term effects are harder to maintain. Pessaries, vaginal cones, and vaginal inserts have been widely used for treatment of SUI and are beneficial in patients who are motivated to use them. Currently in the United States, there is no FDA-approved medication for the treatment of SUI. Conversely, the European Union has approved and used duloxetine. Urethral bulking agents are indicated for patients with intrinsic sphincter deficiency and sometimes used in patients who are not able to undergo surgical procedures for SUI or who have failed said procedures. Three materials are currently FDA approved for urethral bulking in the United States. Many options exist for the nonsurgical management of SUI. This review contains 5 tables and 47 references  Key words:  Stress Urinary Incontinence, conservative treatment, urethral bulking, pelvic floor exercises, incontinence pessaries.  


Urology ◽  
2019 ◽  
Vol 124 ◽  
pp. 78-82 ◽  
Author(s):  
Elizabeth V. Dray ◽  
Marybeth Hall ◽  
Diana Covalschi ◽  
Ann P. Cameron

2014 ◽  
Vol 86 (3) ◽  
pp. 205 ◽  
Author(s):  
Maria Angela Cerruto ◽  
Carolina D’Elia ◽  
Pierpaolo Curti

Stress urinary incontinence (SUI) affects a large proportion of middle-aged and elderly women. When all conservative means are ineffective, a surgical treatment including retropubic suspension, pubovaginal and tension-free slings, is contemplated. Intra-urethral injections with bulking agents have been used as an alternative to the mentioned surgical procedures with alternate results. Many urethral bulking agents are available, such as bovine glutaraldehyde cross linked (GAX) collagen, polytetrafluoroethylene (Teflon), polydimethyl-sillxane elastomer (silicone), carbon coated zirconium beads, hyaluronic acid/dextranomer, and autologous tissues such as fat and cartilage. These substances may be injected in a retrograde or antegrade fashion in the periurethral tissue and whether one route of injection is better than another is not well documented in the literature. We briefly describe the main injection techniques and devices of the most common bulking agents used in the treatment of female SUI.


Sign in / Sign up

Export Citation Format

Share Document